Market revenue in 2021 | USD 96.4 million |
Market revenue in 2028 | USD 134.2 million |
Growth rate | 4.8% (CAGR from 2021 to 2028) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.39% in 2021. Horizon Databook has segmented the Sweden immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Sweden has high life expectancy, and the country operates well in comparisons associated to disease-oriented markers of quality of care and health service outcomes. The healthcare expenditure in Sweden is primarily tax funded (80%) and is equivalent to 11% of GDP in 2018.
With increasing geriatric population and rise in incidence of cancer are expected to boost demand for technological innovation and modern diagnostic tools. Ischemic heart disease, cerebrovascular disease, and lung cancer accounted for the highest number of premature deaths in Sweden, which is expected to increase the need for immunoassay analyzers in the near future.
The prevalence of gonorrhea is also increasing rapidly in Sweden. The number of people suffering from gonorrhea increased from 691 in 1995 to 1,545 in 2015. Increasing incidence of such diseases has positively affected the immunoassay analyzers market largely. Thus, creates lucrative opportunities for to grow their market.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Sweden immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account